Healthcare professionals in Zaragoza II present more than 80 research and innovation projects to improve the patient experience

The 4th Conference has included the participation of representatives from Government of Aragon, IIS Aragon, professionals of Zaragoza II sector and the entity Roche Pharma

Healthcare professionals in Zaragoza II have presented more than 80 research and innovation projects to improve the patient experience, during the celebration, this February, of the IV Conference on Research and Innovation Updates in the Sector.

This Monday, February 23, the Miguel Servet University Hospital (HUMS) in Zaragoza held the final session of the conference, in an edition specially focused on make talent visible and transformation of the Aragonese healthcare system in the framework of Research and Innovation Month, organized by the Research and Innovation Commission of Sector II and the Aragon Health Research Institute (IIS Aragon).

These fourth conferences, which took place in the HUMS Teaching building, were structured as follows: four thematic tables dedicated to research, innovation, the talent of future professionals and innovation applied to healthcare practice.

Overall, the program has brought together experts from various specialties, who have presented ongoing projects, emerging therapeutic strategies and advanced technological solutions, both in Primary and Hospital Care, consolidating the multidisciplinary nature of health innovation in the Zaragoza II sector.

Throughout the sessions, the following topics have been addressed: leading areas, such as artificial intelligence applied to early diagnosis, advanced therapies, digital monitoring of chronic pathologies, tumor biology, neurosciences, humanization of care and continuous improvement methodologies in care processes.

At the Research Roundtable, presentations explored mitochondrial inhibition as a therapeutic strategy in medulloblastoma, the role of the ENEIDA registry in collaborative research, the potential of the eye as a biomarker of neurodegeneration using AI, and tools for educational improvement in inflammatory bowel disease.

Innovation

La Innovation Roundtable It has showcased cutting-edge technological applications: organ-on-chip models for tumor research and reproduction, advanced biosignal analysis for stroke, new approaches in cell and gene therapies, and the integration of artificial intelligence into cardiology practice.

The day dedicated to Future Professionals It has provided a space for residents, students and young researchers to present projects ranging from the optimization of care circuits to digital clinical support tools, reinforcing the commitment of the Zaragoza II sector to training and emerging talent.

Finally, in Monday's session, the Mthat of Innovation in Healthcare Work It has brought together initiatives directly aimed at improving patient experience and clinical efficiency, such as BEHUMANEST to accompany patients during surgical procedures and the validation of the EVICE-SM scale for assessing the impact of nursing care in mental health. 

The day included a keynote address by President y CEO de Blue HealthcareMaría Cordón Muro, on the future of medicine with the increase in life expectancy

Quality and healthcare practice

The acting Minister of Health for the Government of Aragon, José Luis Bancalero Flores, highlighted the participation of residents from various specialties at the closing ceremony of the conference. He stated that the conference showcases best practices in research and innovation with the aim of achieving the highest quality and its implementation in clinical practice.

“The projects presented this month reflect the level, dedication and talent of the professionals at HUMS” and allow progress “towards a more modern, more humane and more innovative healthcare system, thanks to the commitment of those who dedicate their daily efforts to improving the care received by the people of Aragon,” Bancalero stated.

For her part, Silvia Izquierdo Álvarez, president of the Research and Innovation Commission for the Zaragoza II sector, stated that in this fourth edition, “the conference highlights the enormous work that professionals in the sector carry out every day in research and innovation. Our goal is to continue promoting initiatives that arise from clinical practice and to show that any idea, with support and guidance, can become a real project that benefits patients.”

For her part, Rita Casas, head of Roche Pharma for the Northeast region, an organization that supported these workshops, emphasized the company's strong commitment to the development of biomedical innovation in Aragon. “Innovation in healthcare is a shared responsibility; only by working together—government, managers, healthcare professionals, and patient associations—can we achieve progress that leads to better outcomes” for society.

Consolidated meeting

The 4th Conference has included the participation of representatives from Government of Aragon, IIS Aragon, professionals of Zaragoza II sector and the entity Roche Pharmahighlighting the importance of synergy between administration, clinical practice, research and business.

The program has been developed in both face-to-face and streaming formats, facilitating the attendance of a large number of professionals interested in learning about the latest advances in health research and innovation.